Arkolith/Insider Trading/EVLO/Form 4

Epstein David R

DirectorEvelo Biosciences, Inc. (EVLO) · full profile →Form 4 · filed Jun 1, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 31, 2022Option exercise(M)3K—$089K
May 31, 2022Option exercise(M)2K—$086K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 31, 2022Option exercise(M)3K—$03K
May 31, 2022Option exercise(M)2K—$02K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001694665-22-000091) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML